{"id":"W3165137789","doi":"10.1111/bjd.20527","title":"Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dermatrials Research","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Psoriasis; Eczematous dermatitis; Ustekinumab; Ixekizumab; Adverse effect; Population; Atopy; Etanercept; Allergy; Internal medicine; Secukinumab; Disease; Adalimumab; Immunology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03173338,0.0004271996,0.00177035,0.001815385,0.0003067001,0.001792467,0.0008342846,0.001209813,0.001975812],"category_scores_gemma":[0.05979728,0.0002545876,0.002281273,0.002041984,0.0005068465,0.0009989662,0.0007120594,0.001440361,0.0002859074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008688614,"about_ca_system_score_gemma":0.001576873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003675025,"about_ca_topic_score_gemma":0.0006843191,"domain_scores_codex":[0.9771248,0.01059435,0.003938742,0.001244368,0.006598851,0.0004990357],"domain_scores_gemma":[0.8492141,0.06594545,0.05612544,0.004589352,0.0220247,0.002100803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04634668,0.001226992,0.3765281,0.01062714,0.01835402,0.0009062858,0.0005429104,0.001911642,0.003414453,0.00144296,0.08256575,0.4561331],"study_design_scores_gemma":[0.009890886,0.02947462,0.708669,0.00624864,0.03387124,0.005566614,0.0005254194,0.01891389,0.008011343,0.003526366,0.1750011,0.0003010384],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7319248,0.1398726,0.0196904,0.06251649,0.007838863,0.003104548,0.02458083,0.00052208,0.009949467],"genre_scores_gemma":[0.9140719,0.02170535,0.01245252,0.02257817,0.01790239,0.001073616,0.008190796,0.0001236173,0.001901613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03173338,"threshold_uncertainty_score":0.1678241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01054155446990465,"score_gpt":0.2099374867063248,"score_spread":0.1993959322364201,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}